Balch Andrea, Mackin Andrew
Las Vegas Veterinary Referral Center, USA.
Compend Contin Educ Vet. 2007 Apr;29(4):230-8; quiz 239.
The treatment of primary immune-mediated hemolytic anemia involves short-term oxygen-carrying support and long-term immunosuppressive therapy. Therapeutic options include blood transfusion, standard and more speculative immunosuppressive agents, splenectomy, and prevention of thromboembolic disease. This article also discusses the prognosis and prognostic indicators.
原发性免疫介导性溶血性贫血的治疗包括短期的携氧支持和长期的免疫抑制治疗。治疗选择包括输血、标准及更具探索性的免疫抑制剂、脾切除术以及预防血栓栓塞性疾病。本文还讨论了预后及预后指标。
Zotero 插件